A Unique Target-First Approach to Discover and Develop Promising Therapies

At Cullinan Therapeutics, we embrace close collaboration through our ‘innovation without borders’ approach. We are looking for partners with areas of expertise that complement and strengthen our own. Our co-commercialization, co-development and co-research partnerships emphasize idea sharing in which subject-matter experts on both teams provide unmatched perspectives to most effectively advance our programs together. A robust partnership network fueled by external collaboration helps advance new ideas that have a higher chance of benefiting patients. We are always looking for opportunities to collaborate with academic institutions as well as pharmaceutical companies through our partnerships and collaborations to work towards our common goal of helping patients by pushing the frontiers of scientific promise.

cancer tumor cell
Image of Circles

Collaboration is key

Strong partnerships result in innovative clinical programs.

Our Differentiated Clinical-Stage Pipeline

We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases.